Suicidal ideation

Suicidal ideation is the experience of recurring thoughts about ending one's own life, arising acutely as a drug effect rather than from a standing psychiatric condition.

As a drug effect it is acute and dose-proportional, easing as the substance wears off. It ranges from passive thoughts that life is not worth continuing to active urges, and at its most intense carries real risk of irreversible harm.

It is rare relative to most adverse effects but is reported across several drug classes. It is most commonly induced at high doses or during the comedown from stimulants such as MDMA and methamphetamine, and as a rebound from depressants such as gabapentin and pregabalin. It also appears under psychedelics such as MDA and dissociatives such as rolicyclidine.

Suicidal ideation is felt as a narrowing of perspective in which the future becomes unimaginable and existence feels unbearable: thoughts loop around hopelessness, worthlessness, or a conviction that others would be better off without the person present.

It commonly comes with heaviness in the chest, emotional numbness, and an aching exhaustion that makes ordinary cognition difficult. Attending to the thoughts intensifies them. At high doses, particularly under stimulants during the comedown, the ideation can sharpen into active, distressing urges.

Suicidal ideation arises through different pathways depending on the drug class:

• Stimulants — monoamine depletion during heavy use produces a dysphoric crash in which ideation can emerge.
• Depressants — gabapentinoids destabilize mood paradoxically; ideation is most often reported during taper or abrupt withdrawal.
• Psychedelics — act on 5-HT2A receptors; during difficult experiences, existential distress can cross into ideation.
• Dissociatives — NMDA receptor blockade produces altered self-states in which self-destructive thoughts may arise.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both likelihood and severity, though paradoxical cases occur at low to moderate doses of depressants. Set and setting matter significantly — emotional exhaustion, isolation, and unresolved psychiatric history increase risk, particularly under stimulants and psychedelics.

Prior depressive episodes or a history of suicidal ideation are the strongest trait-level predictors. Entering a session with significant pre-existing distress tends to be self-fulfilling. Supportive company and a stable emotional baseline reduce risk.